Chronic disseminated candidiasis in a patient with acute leukemia - an illustrative case and brief review for clinicians.
Chronic disseminated candidiasis
Hematopoietic stem cell transplant
Hepatosplenic candidiasis
Immunocompromised
Neutropenia
Neutropenic fever
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
06 Mar 2024
06 Mar 2024
Historique:
received:
29
10
2023
accepted:
24
02
2024
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
6
3
2024
Statut:
epublish
Résumé
Chronic disseminated candidiasis (CDC) is a severe but rarely seen fungal infection presenting in patients with hematologic malignancies after a prolonged duration of neutropenia. A high index of suspicion is required to diagnose CDC as standard culture workup is often negative. While tissue biopsy is the gold standard of diagnosis, it is frequently avoided in patients with profound cytopenias and increased bleeding risks. A presumptive diagnosis can be made in patients with recent neutropenia, persistent fevers unresponsive to antibiotics, imaging findings of hypoechoic, non-rim enhancing target-like lesions in the spleen and liver, and mycologic evidence. Here, we describe the case of an 18-year-old woman with relapsed B-cell acute lymphoblastic leukemia treated with re-induction chemotherapy who subsequently developed CDC with multi-organ involvement. The diagnosis was made based on clinical and radiologic features with positive tissue culture from a skin nodule and hepatic lesion. The patient was treated for a total course of 11 months with anti-fungal therapy, most notably amphotericin B and micafungin, and splenectomy. After initial diagnosis, the patient was monitored with monthly CT abdomen imaging that showed disease control after 5 months of anti-fungal therapy and splenectomy. The diagnosis, treatment, and common challenges of CDC are outlined here to assist with better understanding, diagnosis, and treatment of this rare condition.
Identifiants
pubmed: 38448809
doi: 10.1186/s12879-024-09172-9
pii: 10.1186/s12879-024-09172-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
296Informations de copyright
© 2024. The Author(s).
Références
Pappas PG, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026.
doi: 10.1038/nrdp.2018.26
pubmed: 29749387
Perez JC. Fungi of the human gut microbiota: roles and significance. Int J Med Microbiol. 2021;311(3):151490.
doi: 10.1016/j.ijmm.2021.151490
pubmed: 33676239
Kullberg BJ, Arendrup MC. Invasive Candidiasis N Engl J Med. 2015;373(15):1445–56.
doi: 10.1056/NEJMra1315399
pubmed: 26444731
Arastehfar A et al. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi (Basel), 2021. 7(4).
Chang H, et al. Clinical feature, image findings and outcome of hepatosplenic candidiasis in patients with acute myeloid leukemia. Biomed J. 2021;44(6 Suppl 2):S252–7.
doi: 10.1016/j.bj.2020.11.006
pubmed: 35292266
Rammaert B, Desjardins A, Lortholary O. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis. Mycoses. 2012;55(3):e74–84.
doi: 10.1111/j.1439-0507.2012.02182.x
pubmed: 22360318
Chen CY, et al. Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies. BMC Infect Dis. 2019;19(1):635.
doi: 10.1186/s12879-019-4260-4
pubmed: 31315582
pmcid: 6637637
Cornely OA, Bangard C, Jaspers NI. Hepatosplenic candidiasis. Clin Liver Dis (Hoboken). 2015;6(2):47–50.
doi: 10.1002/cld.491
pubmed: 31040987
Boussen I, et al. Hepatosplenic candidiasis in patients with hematological malignancies: a 13-Year retrospective cohort study. Open Forum Infect Dis. 2022;9(4):ofac088.
doi: 10.1093/ofid/ofac088
pubmed: 35355897
pmcid: 8962726
Pagano L, et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica. 2002;87(5):535–41.
pubmed: 12010669
Senn L, et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis. 2008;46(6):878–85.
doi: 10.1086/527382
pubmed: 18260755
Shalin SC, Ferringer T, Cassarino DS. PAS and GMS utility in dermatopathology: review of the current medical literature. J Cutan Pathol. 2020;47(11):1096–102.
doi: 10.1111/cup.13769
pubmed: 32515092
Thaler M, et al. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med. 1988;108(1):88–100.
doi: 10.7326/0003-4819-108-1-88
pubmed: 3276268
Donnelly JP, et al. Revision and update of the Consensus definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–76.
doi: 10.1093/cid/ciz1008
pubmed: 31802125
Pappas PG, et al. Clinical practice Guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.
doi: 10.1093/cid/civ933
pubmed: 26679628
Legrand F, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis. 2008;46(5):696–702.
doi: 10.1086/527390
pubmed: 18230039
Yu S, et al. Splenectomy for treating hepatosplenic candidiasis: two cases and literature review suggesting its feasibility. Heliyon. 2023;9(4):e15114.
doi: 10.1016/j.heliyon.2023.e15114
pubmed: 37089309
pmcid: 10113846